Body mass index and risk of BPH: a meta-analysis (Q37970018)

26 August 2017

0 references

Body mass index and risk of BPH: a meta-analysis (English)

1 reference

26 August 2017

0 references

S Wang

1

1 reference

26 August 2017

Q Mao

2

1 reference

26 August 2017

Y Lin

3

1 reference

26 August 2017

J Wu

4

1 reference

26 August 2017

X Wang

5

1 reference

26 August 2017

X Zheng

6

1 reference

26 August 2017

L Xie

7

1 reference

26 August 2017

20 December 2011

1 reference

Prostate Cancer and Prostatic Diseases

26 August 2017

1 reference

26 August 2017

15

1 reference

26 August 2017

3

1 reference

26 August 2017

265-272

1 reference

https://scigraph.springernature.com/pub.10.1038/pcan.2011.65

26 August 2017

0 references

cites work

Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Benign prostatic hyperplasia: dietary and metabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Quantitative synthesis in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Effects of components of metabolic syndrome on sexual function in Korean BPH/LUTS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Effects of obesity on lower urinary tract symptoms in Korean BPH patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Urinary symptoms, quality of life and sexual function in patients with benign prostatic hypertrophy before and after prostatectomy: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Lower urinary tract symptoms, prostate volume and uroflow in norwegian community men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Life-style in patients with LUTS suggestive of BPH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Risk factors for benign prostatic hyperplasia in South Korean men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Relationship of serum sex-steroid hormones and prostate volume in African American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Risk factors for lower urinary tract symptoms in a population-based sample of African-American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Risk factors for surgery for prostatic hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

The epidemiology of benign prostatic hyperplasia: a study in Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Metabolic factors associated with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Risk factors for surgically treated benign prostatic hyperplasia in Western Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

History of weight and obesity through life and risk of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Cigarette smoking, obesity, and benign prostatic hypertrophy: a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Concordance rates and modifiable risk factors for lower urinary tract symptoms in twins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

The prevalence and correlates of urinary tract symptoms in Norwegian men: the HUNT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Central obesity as a risk factor for prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

An animal model to study lower urinary tract symptoms and erectile dysfunction: the hyperlipidaemic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Increased oxidative stress in obesity and its impact on metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Asymptomatic inflammation and/or infection in benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Body size and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

What causes prostate cancer? A brief summary of the epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

UROLOGIC DISEASES IN AMERICA PROJECT: BENIGN PROSTATIC HYPERPLASIA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

The development of human benign prostatic hyperplasia with age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Heterogeneity testing in meta-analysis of genome searches

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Significant association between serum dihydrotestosterone level and prostate volume among Taiwanese men aged 40–79 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Risk factors for lower urinary tract symptoms in elderly men. For the Prostate Study Group of the Austrian Society of Urology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Obesity and benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Re: Risk factors for benign prostatic hypertrophy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Obesity and benign prostatic enlargement: a large observational study in China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Risk factors for lower urinary tract symptoms in southern Chinese men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

Distribution of Inflammation, Pre-Malignant Lesions, Incidental Carcinoma in Histologically Confirmed Benign Prostatic Hyperplasia: A Retrospective Analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.65

31 March 2020

Identifiers

DOI

10.1038/PCAN.2011.65

1 reference

26 August 2017

1 reference